These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32351967)

  • 1. Editorial: Frailty and Herbal Medicines- From Molecular Mechanisms to Clinical Efficacy.
    Ataka K; Takahashi R; Li JB; Iizuka N; Inui A
    Front Nutr; 2020; 7():41. PubMed ID: 32351967
    [No Abstract]   [Full Text] [Related]  

  • 2. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty.
    Uto NS; Amitani H; Atobe Y; Sameshima Y; Sakaki M; Rokot N; Ataka K; Amitani M; Inui A
    Front Nutr; 2018; 5():126. PubMed ID: 30619872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Effects of Ninjin'yoeito on Physical Frailty in Mice.
    Otsuka S; Fukumaru K; Tani A; Takada S; Kikuchi K; Norimatsu K; Matsuzaki R; Matsuoka T; Sakakima H; Omiya Y; Mizuno K; Matsubara Y; Maruyama I
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disuse muscle atrophy-improving effect of ninjin'yoeito in a mouse model.
    Takemoto R; Sejima T; Han LK; Michihara S; Takahashi R
    Neuropeptides; 2021 Dec; 90():102199. PubMed ID: 34610544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report.
    Kuniaki H; Akihiko T; Tetsuya H; Hatsuko M; Tomoko K; Shin O; Sojiro K; Mayumi Y; Fumihiro Y; Shintaro S; Tsukasa O; Hironori S
    Front Nutr; 2018; 5():71. PubMed ID: 30234120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ninjin'yoeito, a traditional Japanese medicine, increases dopamine content in PC12 cells.
    Miyazaki S; Omiya Y; Mizoguchi K
    Biosci Biotechnol Biochem; 2021 Oct; 85(11):2274-2280. PubMed ID: 34529031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ninjin'yoeito Targets Distinct Ca
    Goswami C; Dezaki K; Wang L; Inui A; Seino Y; Yada T
    Front Nutr; 2020; 7():104. PubMed ID: 32766273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty.
    Kashima M
    Front Nutr; 2021; 8():547512. PubMed ID: 33937301
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and Effectiveness of Ninjin'yoeito: A Utilization Study in Elderly Patients.
    Suzuki S; Aihara F; Shibahara M; Sakai K
    Front Nutr; 2019; 6():14. PubMed ID: 30873411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good Rehabilitation Outcomes and Improved Nutritional Status After Treatment With the Japanese Herbal Medicine Ninjin'yoeito in an Elderly Patient With Hip Fracture and Sarcopenia: A Case Report.
    Morinaga A; Nakamura H; Hattanmaru K; Rokot NT; Kimura Y; Ito T
    Front Nutr; 2020; 7():85. PubMed ID: 32714940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
    Matsumoto T; Takiyama M; Sakamoto T; Kaifuchi N; Watanabe J; Takahashi Y; Setou M
    J Ethnopharmacol; 2021 Oct; 279():114332. PubMed ID: 34129897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Clinical Study of Ninjin'yoeito With Regard to Frailty.
    Sakisaka N; Mitani K; Sempuku S; Imai T; Takemoto Y; Shimomura H; Ushiroyama T
    Front Nutr; 2018; 5():73. PubMed ID: 30320119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the usefulness of Ninjin'yoeito Kampo medicine in combination with rehabilitation therapy in patients with frailty complicated by intractable dizziness.
    Arai M
    Neuropeptides; 2021 Dec; 90():102189. PubMed ID: 34481223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Ninjin'yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice.
    Amitani H; Chiba S; Amitani M; Michihara S; Takemoto R; Han L; Fujita N; Takahashi R; Inui A
    Front Pharmacol; 2022; 13():973897. PubMed ID: 36353482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National trends in the prescribing of Ninjin'yoeito, a Kampo medicine, for older adults from 2015 to 2020 in Japan.
    Sasaki Y; Hamada S; Arai I; Sakata N
    Geriatr Gerontol Int; 2023 May; 23(5):396-398. PubMed ID: 36967456
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
    Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term administration of ninjin'yoeito to treat frailty in older adults: A case series.
    Sakisaka N
    Neuropeptides; 2022 Jun; 93():102244. PubMed ID: 35381491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kampo medicines for supportive care of patients with cancer: A brief review.
    Motoo Y; Cameron S
    Integr Med Res; 2022 Jun; 11(2):100839. PubMed ID: 35242536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onion component, isoalliin, stimulates feeding and activates the arcuate nucleus neuropeptide Y, ghrelin- and Ninjin'yoeito-responsive neurons.
    Wang L; Han W; Iwasaki Y; Yermek R; Sharp GWG; Seino Y; Yada T
    Neuropeptides; 2021 Oct; 89():102180. PubMed ID: 34293597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.